The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs—Part B: Prostate and Urinary Tract Tumors,European Urology

当前位置： X-MOL 学术 › Eur. Urol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs—Part B: Prostate and Urinary Tract Tumors
European Urology ( IF 23.4 ) Pub Date : 2022-08-11 , DOI: 10.1016/j.eururo.2022.07.002
George J Netto ₁ , Mahul B Amin ₂ , Daniel M Berney ₃ , Eva M Compérat ₄ , Anthony J Gill ₅ , Arndt Hartmann ₆ , Santosh Menon ₇ , Maria R Raspollini ₈ , Mark A Rubin ₉ , John R Srigley ₁₀ , Puay Hoon Tan ₁₁ , Satish K Tickoo ₁₂ , Toyonori Tsuzuki ₁₃ , Samra Turajlic ₁₄ , Ian Cree ₁₅ , Holger Moch ₁₆

Affiliation

Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA.
Department of Pathology and Laboratory Medicine, University of Tennessee Health Science Center, Memphis, TN, USA; Department of Urology, USC Keck School of Medicine, Los Angeles, CA, USA.
Barts Cancer Institute, Queen Mary University of London, London, UK; Department of Cellular Pathology, Barts Health NHS Trust, London, UK.
Department of Pathology, Medical University of Vienna, General Hospital of Vienna, Vienna, Austria.
Sydney Medical School, University of Sydney, Sydney, Australia; NSW Health Pathology, Department of Anatomical Pathology, Royal North Shore Hospital St Leonards, Sydney, Australia; Pathology Group, Kolling Institute of Medical Research, Royal North Shore Hospital St Leonards, Sydney, Australia.
Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany.
Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
Histopathology and Molecular Diagnostics, University Hospital Careggi, Florence, Italy.
Department for BioMedical Research (DBMR), Bern Center for Precision Medicine (BCPM), University of Bern and Inselspital, Bern, Switzerland.
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
Division of Pathology, Singapore General Hospital, Singapore.
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Department of Surgical Pathology, AichiMedicalUniversity Hospital, Nagakut, Japan.
The Francis Crick Institute and The Royal Marsden NHS Foundation Trust, London, UK.
International Agency for Research on Cancer (IARC), World Health Organization, Lyon, France.
Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.

The 2022 World Health Organization (WHO) classification of the urinary and male genital tumors was recently published by the International Agency for Research on Cancer. This fifth edition of the WHO “Blue Book” offers a comprehensive update on the terminology, epidemiology, pathogenesis, histopathology, diagnostic molecular pathology, and prognostic and predictive progress in genitourinary tumors. In this review, the editors of the fifth series volume on urologic and male genital neoplasms present a summary of the salient changes introduced to the classification of tumors of the prostate and the urinary tract.

中文翻译：

2022 年世界卫生组织泌尿系统和男性生殖器官肿瘤分类——B 部分：前列腺和泌尿道肿瘤

国际癌症研究机构最近发布了 2022 年世界卫生组织 (WHO) 泌尿和男性生殖器肿瘤分类。第五版 WHO“蓝皮书”全面更新了术语、流行病学、发病机制、组织病理学、诊断分子病理学以及泌尿生殖系统肿瘤的预后和预测进展。在这篇综述中，泌尿系统和男性生殖器肿瘤系列第五卷的编辑们总结了前列腺和泌尿道肿瘤分类中引入的显着变化。

更新日期：2022-08-11

点击分享查看原文

点击收藏

阅读更多本刊最新论文本刊介绍/投稿指南

全部期刊列表>>